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1. Introduction 
The clinical benefit of cardiac pacemakers has been long proven through numerous studies. 
Millions of pacemakers have been implanted worldwide and, as a result the quality of life 
for these patients has been drastically improved, not forgetting the reduced morbidity and 
mortality. The first stimulations through transthoracic electrodes were pioneered by Zoll in 
the early fifties (Zoll, 1952)), then came percutaneous endocardial pacing in 1959 (Furman & 
Schwedel. (1959).. A “permanent” pacemaker using epicardial electrodes was first described 
in 1960 (Chardack, 1960). Pacemakers and implantation techniques have progressed rapidly 
since the then; Generators are more reliable, more compact, filled with micro-electronic 
components, can be controlled automatically and remotely and thus providing more options 
for programmation and monitoring and a longer pacemaker life span (Kusomoto & 
Goldschlager, 1996; Trohman, et al, 2004).  Leads are thinner and more resistant to damage 
and thus equally longer-lasting.  
The latest European guidelines published in 2007 confirmed the classic indications; 
symptomatic bradyarrhythmias including sinus node dysfunction and atrioventricular or 
intraventricular conduction disturbances (Vardas et al., 2007). The guidelines also 
recommended cardiac pacing for specific conditions (vasovagal syncope, hypertrophic 
cardiomyopathy, heart failure with prolonged QRS duration, etc). Since over 10 years, left 
ventricular resynchronisation therapy has proved to be beneficial to patients presenting 
heart failure with complete left bundle block in association with optimal medical treatment; 
the European guidelines were updated for this indication in 2010 (Dickstein,2010) 
The correct implantation of a pacemaker is capital for optimal function. A recent trend 
shows pacemaker implantation can be performed as successfully in the electrophysiology 
study environment as in the operating room (Garcia-Bolao & Alegria, 1999). This requires a 
centre with a qualified team of cardiologists as well as experienced nursing and technical 
staff. Continued education for the team and follow-up of complications is essential. The 
cardiologists’ or surgeons’ experience, and the volume of pacemakers implanted in the 
centre, plays a role in reducing post-implantation complications; thus, guidelines discourage 
this procedure in centres with a low volume of implantation.  
Despite these precautions, some early complications, occurring within the first 6 weeks after 
implantation, may be observed. Their incidence is probably underestimated (approximately 
7%), as is their severity (Kiviniemi et al., 1999; Klug et al., 2003). Less than 5% have to incur 
reintervention. Per-procedure mortality is extremely rare; only one case was observed in the 
cohort of 650 patients implanted at Columbia-Presbyterian Medical Centre. The dutch 
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database FLOOWPACE PM has indexed/listed six variables associated with at least one 
complication prior to hospital discharge; a low body mass index,  history of heart failure 
(one of the principal indications for implantation), a subclavian venous access, an active 
fixation auricular pacing lead, and double lead implantation. These patients should be 
considered at risk for complications (van Eck et al., 2007). 
2. Clinical cases 
Early complications of pacemaker implantation are not uncommon, even in an experienced 
team of cardiologists or surgeons. Before discharge, careful evaluation of the pacing system 
is required. Diagnosis of malfunction is not always evident. Most of the patients needed an 
invasive procedure or medical intervention to prevent further morbidity. 
Through practical clinical examples, we aim to elaborate the principal complications of 
electronic implanted cardiac devices, as well as discuss situations in which the presence of 
such a device needs to be kept in mind for the work-up of disorders that may or may not 
seem pacemaker-related. 
2.1 Case 1 - Latrogenic pneumothorax resulting from subclavian puncture  
A 61 year old man presents to his general practitioner with right thoracic pain and dyspnoea, 
progressively worsening since three days. He was discharged from cardiology a week before, 
for implantation of a double chamber pacemaker for sick sinus syndrome with symptomatic 
atrial fibrillation and bradycardia. Clinical examination revealed good cicatrisation of the 
implantation site, normal cardiac sounds with no murmur, but abolished respiratory sounds in 
the right lung. Twelve-lead electrocardiogram (EKG) showed a sinus rhythm with paced 
ventricular response (typical left bundle block pattern). Chest X-ray confirmed the presence of 
a complete right pneumothorax (Figure 1). The patient was therefore treated with a chest tube 
and his recovery was uneventful. The additional hospital stay was three days.  
 
 
Fig. 1. Chest X-ray showing complete right pneumothorax, which was treated with a chest tube. 
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Comments: Iatrogenic pneumothorax after subclavian venous access is a rare complication 
whose incidence varies from 1-5% depending on the series, on the realisation of routine 
post-procedural chest X-ray and on the exact definition of this complication (consideration 
of both complete and partial pneumothorax, the need for chest tube insertion, hemothorax 
or gas embolism) (Res et al., 2004).  It is usually an immediate complication and is rarely 
witnessed after discharge. To avoid this complication, access through a central cephalic vein 
is possible. However, this technique is subject to failure in approximately 20%. The 
operator’s anatomical knowledge and experience reduce this risk. Pneumothorax is usually 
asymptomatic and resolves spontaneously in most cases. It is to be suspected in all patients 
presenting with dyspnoea, unexplainably low blood pressure and variable or elevated 
stimulation thresholds. Chest tube placement with aspiration is necessary if pneumothorax 
exceeds 10% of lung volume, if tension pneumothorax or hemothorax are diagnosed. 
2.2 Case 2 - Skin necrosis, suture line failure, and lead erosion due to a large pocket 
hematoma  
An 80 year old male needed pacing for complete atrioventricular block is re-admitted three 
months after implantation. Despite daily wound care by a home-based nurse, the suture line at 
the site of implantation would not cicatrize. Patient history included myocardial infarction for 
which percutaneous cardiac intervention (PCI) with a bare metal stent was performed, as well as 
receiving classical medical treatment that included clopidogrel and aspirin on a daily basis. After 
implantation, a large hematoma formed in the generator pocket. A conservative treatment was 
initially proposed. On re-admission, the hematoma had almost completely disappeared, but 
severe skin necrosis was impeding site closure to the extent that the leads were visible with the 
naked eye. The absence of infection, as proved by numerous negative swab cultures, allowed for 
the pacemaker generator to be re-implanted under the pectoralis muscle. 
 
 
Fig. 2. Hematoma. Lack of suture line healing, pacemaker leads visible. 
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Comments: Pocket hematoma is the most frequent complication (5% of cases) and can lead 
to prolonged hospital stay and in the latter case, re-implantation (1-2%) (Kiviniemi et al., 
1999 ; Wiegand et al., 2004). Risk factors include use of high doses of low molecular weight 
heparin, of the association aspirin-clopidogrel, and inexperienced operator. Aspirin alone or 
an oral anticoagulant like warfarin, to take international normalized ratio (INR) of < 2.0, 
does not increase the risk of hematoma. Electrocautery or a second look to the pocket is 
useful to minimize bleeding and the risk of large hematoma. Selective use of topical 
thrombin is reserved for high risk patients; in Reynolds’s series, the incidence of significant 
hematoma dropped from 20.8% to 8%. Sometimes drain placement may be necessary and 
sufficient. Evacuation of hematoma is realised in less than 0.5% with a major risk of 
infection; potential reasons include persistent bleeding, pain refractory to analgesics, failed 
healing and skin necrosis. 
2.3 Case 3 - Recurrent syncope due to lead displacement  
A 60 year old female patient with no medical history and under no current treatment was 
admitted for complete atrioventricular block causing shortness of breath and dizziness. 
Implantation of a double chamber pacemaker was performed with ease. P/R sensings were 
measured at 3.1 mV and 7.8 mV respectively, and both thresholds for stimulation are 0.5 
volt/0.4 msec.  The next day, the patient represented with dizziness and faints. Lead 
displacement was suspected. EKG no longer showed physiological stimulation and chest X-
ray confirmed lead displacement (Figure 3). Lead repositioning and active fixation was 
performed successfully. 
 
 
 
 
Fig. 3. Chest X-ray showing migration of both atrial and ventricular leads. 
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• Failure to OUTPUT: no pacemaker activity. NO SPIKE 
• battery failure or EOL (end of life), battery trauma  
• lead problems : lead fracture, lead dislodgement, fractured lead insulation, poor 
lead connection 
• oversensing causes (myopotentials, electromagnetic interference, cross-talk 
phenomenon) 
• "cross-talk” phenomenon  
• extreme electromagnetic interference 
• pseudo-malfonction : hystérésis, normal algorithmes (AV conduction) 
• Failure to CAPTURE: no depolarisation of the cavity. SPIKE without  P/QRS 
complexes 
• normal situation : Functional non-capture—output delivered during refractory 
period 
• inappropriate programming of the pacemaker (too low safe margin) 
• lead problems : lead fracture, lead dislodgement, fractured lead insulation, poor 
lead connection 
• myocardial perforation  
• elevated pacing threshold :  
o myocardial infarction (necrosis) at the lead tip  
o drugs (eg, flecainide)  
o dyskaliemia  
o metabolic abnormalities (eg, acidosis, alkalosis) 
• Oversensing (Oversensing occurs when a pacemaker incorrectly senses 
cardiac/noncardiac electrical activity and is inhibited from pacing): 
• Myopotentials or muscular activity (particularly the diaphragm or pectoralis 
muscles)  
• cross-talk phenomenon   
• electromagnetic interference (eg, Magnetic Resonance Imaging (MRI)  
• lead fracture and fractured lead insulation 
• Undersensing (Undersensing occurs when a pacemaker incorrectly misses intrinsic 
depolarization and paces despite intrinsic activity) 
• Normal device function—misinterpretation : triggered mode, fusion and 
pseudo-fusion beats, functional undersensing (long refractory periods, blanking 
period, safety pacing, oversensing) 
• poor lead positioning (poor intrinsic signal amplitude), lead dislodgment, lead 
fibrosis or thrombosis 
• magnet application  
• battery depletion  
• drugs (eg, flecainide, amiodarone)  
• metabolic abnormalities (eg, acidosis, alkalosis) 
• dyskaliemia (eg, hyperkaliemia)  
• hypothyroidism  
• ischemia and myocardial infarction  
• or electrical shock (transient)
Table I. Pacemaker Troubleshooting and early complications of pacemaker insertions 
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Comments: Lead displacement can be found in 2-10% of cases depending on the series 
(Kiviniemi et al., 1999 ; van Eck et al., 2007). Atrial leads migrate more often than ventricular 
leads. Active fixation reduces the risk, especially in patients having undergone cardiac 
surgery. Manifestations include undersensing, failure to capture and increase in pacing 
thresholds. Repositioning of leads is primordial. Causes of undersensing include lead 
displacement, fibrosis at the site of fixation of the lead, myocardial ischemia and necrosis, 
some antiarrhythmic agents (flecainide), dyskaliemia, or transient undersensing following 
an electric shock (Table I) (de Meester, 2008). When lead displacement is induced by the 
patient, following a repetitive rotational movement (twisting of the box) and leading to 
winding of the leads around the generator, we talk of Twiddler’s syndrome; this is observed 
in certain psychiatric cases, or when the pocket is too big for the pacemaker generator. 
2.4 Case 4 - Minor right ventricular perforation  
A 77 year-old patient had a physiological pacemaker implanted for symptomatic sinus 
bradycardia, with sinus arrest. A few days after the intervention, she presented with 
continuous chest pain. Upon clinical examination, blood pressure was 130/80 mmHg, heart 
sounds were regular but a pericardial friction rub was audible. EKG showed a sinus rhythm 
with ventricular capture. Chest X-ray revealed a ventricular lead projecting further than the 
apex (Figure 4). Cardiac ultrasounds confirmed myocardial perforation by the lead and a 
minimal pericardial effusion. We decided to abstain from removing the lead, which would 
have been to some extent invasive in this elderly patient. Treatment by anti-inflammatory 
drug was installed and was sufficient for pain relief. 
 
 
 
 
Fig. 4. Chest X-ray showing atrial and ventricular leads, with the ventricular lead clearly 
beyond the cardiac shadow 
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Comments: Cardiac perforation is a serious complication, with risk of tamponnade and 
death. It occurs in less than 2% of cases (Ellenbogen et al., 2002). Clinical symptoms are 
variable, including chest pain, shortness of breath and more rarely hypotension and shock. 
Advanced age, use of active fixation leads and operator inexperience are contributing 
factors (Mahapatra et al., 2005). Furthermore, atrial leads seem to perforate more frequently 
(Hirschl et al., 2007). The new Magnetic Resonance Imaging (MRI)-compatible leads are 
more rigid, but increased frequency of perforation does not seem to be induced by the use of 
these leads. Treatment is not standardised, but removal (and replacement) of these leads is 
crucial in the case of tamponnade and shock. Pericarditis without perforation has been 
observed in 5% of cases and must lead to close follow-up. Figure 5 illustrates a case of  
tamponnade. The patient remained stable after drainage. 
 
 
Fig. 5. Chest scan showing significant pericardial effusion, responsible for pre-tamponnade 
and shock. 
2.5 Case 5 - Skin erosion and exterisation of the generator 
An 85 year old female patient is admitted for malaise and confusion. Medical history is 
positive for asthma treated regularly by corticoids and B2 mimetic aerosols. EKG shows a 
complete atrioventricular block and, after excluding all reversible causes, a physiological 
pacemaker is implanted. No complications are noted during her hospital stay. Having 
regained her autonomy and the confusional episode resolved, the patient returns to her old 
age home with instructions for routine care for the following weeks. A follow-up is 
programmed at six weeks and the cardiologist is confronted with a case of skin erosion and 
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exteriorisation of the pacemaker generator (Figure 6). Due to the high risk of infection in this 
case, the device is removed and a new device is implanted on the contra-lateral side after six 
weeks of antibiotherapy and with negative hemocultures. 
 
 
Fig. 6. Erosion and exteriorisation of pacemaker generator in our elderly patient. 
Comments: Skin erosion is caused by the pacemaker generator, and is usually a result of 
pocket infection. Other precipitating factors can be present, for example, the extremely 
fragile skin of elderly patients, a pocket that is too small, precarious subcutaneous fat, 
chronic use of corticoids, and use of abrasive disinfectants (Kiviniemi et al., 1999). 
Exteriorisation of a generator, and/or a lead, is always associated with bacterial 
contamination, making removal of the material an obligation, accompanied by 
antibiotherapy and eventually re-implantation on the contra-lateral side. Skin erosion is 
hence to be sort for and detected before exteriorisation. This is rarely an early complication, 
and incidence is estimated to be 1%. 
2.6 Case 6 - Ventricular lead malposition and right bundle branch block morphology 
on EKG 
A 55 year old patient with history of hypertension, obesity, diabetes, anterior myocardial 
infarction and severe left ventricular dysfunction has a defibrillator implanted in primary 
prevention of sudden death. The follow-up is satisfactory with acceptable sensing, impedance 
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and threshold stimulation values on the device programmer. EKG shoes a sinus rhythm with 
evident old anterior infarction. Chest X-ray, performed in a recumbent position and under 
non-optimal condition seems satisfactory and the patient is discharged. Upon follow-up one 
month later, the parameters of the defibrillator are still satisfactory, but the ventricular 
stimulation shows atypical right bundle block. Chest X-ray confirms the suspected left 
ventricular stimulation, via a permeable foramen ovale (Figure 7). Lead replacement is 
indicated seeing the high risk of thrombo-embolic complications in this young patient. 
 
 
Fig. 7. Chest X-ray showing a ventricular lead that is located higher than usual; this lead is 
in the left ventricle, having gone through a patent foramen ovale. 
Comments: an erroneous lead placement is extremely rare. It remains possible in patients 
with a patent foramen ovale or an atrial septal defect. Less than twenty cases are reported in 
the literature (Allie et al, 2000; Blommaert et al., 2000 ; Van Gelder al, 2000; Le Dolley et al, 
2009). An EKG during stimulation and chest X-ray in an upright position (antero-posterior 
and lateral takes) are recommended. The risk of thrombo-embolism, including stroke, of 
mitral insufficiency should be evaluated. Repositioning of the lead or long term 
anticoagulation should be considered. When right bundle branch block pacing morphology 
appears in a patient with a permanent or temporary transvenous right ventricular 
pacemaker, myocardial perforation or malposition of the pacing lead must be ruled out, 
even though the patient may be asymptomatic. The overall causes of right bundle branch 
block morphology include: 
• erroneous left ventricular lead placement in patient with an atrial septal defect 
• biventricular stimulation or cardiac resynchronisation therapy (CRT) (Figure 8) 
• epicardial lead placement.  
• some cases of  “normal” right ventricular apical stimulation 
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Fig. 8. Chest X-ray showing implantation of 3 leads including a left ventricular lead placed 
in a branch of the coronary sinus (cardiac resynchronisation therapy).  
2.7 Case 7 - Twiddler syndrome in a psychiatric patient 
A 68 year old patient, with a history of chronic obstructive pulmonary disease and 
psychosis, underwent pacemaker implantation for repeated loss of consciousness due to 
sinus hypersensitivity. Carotid sinus massage resulted in 10 second pauses. The pacemaker 
was set in double chamber mode and after satisfactory programmation control (P-R sensing 
2.5 mV and 12.5 mV, impedance at 564 ohms and 496 ohms respectively, stimulation 
thresholds at 0.5 volts/0.4 msec), the patient was discharged to his psychiatric institution. At 
one month follow-up, the patient has no complaints, though anamnesis is laborious. Check-
up of the stimulator shows absence of detection of both P and R waves, and absence of 
atrioventricular capture despite maximal stimulation. Displaced leads are suspected and 
confirmed by chest x-ray (Figure 9). The patient later admits to having manipulated the pace 
generator by repeatedly twisting it around. Correct repositioning and fixation of the leads 
were conducted.  
 
Comments: Twiddler's syndrome is describes as the migration of cardiac stimulator leads 
due to repetitive rotatory movements of the generator in its pocket, secondary to 
manipulation by the patient himself, which may be  intentional or non-intentional (for 
example, sportsmen). In certain cases, the stimulation of displaced leads can cause pectoral 
muscle contraction, or life-threatening symptoms in the case of pacemaker dependency 
(Nicholson et al, 2003; Castillo & Cavusoglu, 2006; Essoh et al., 2010) (Figure 10).  
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Fig. 9. Chest X-ray showing displaced lead (ventricular lead tip indicated by the star).  
 
 
Fig. 10. Chest X-ray showing dual-coil ventricular lead displacement, causing pectoral 
permanent stimulation, in a case previously reported by our team (Essoh et al, 2010). 
Repositioning the lead was required and successfully reported. 
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Risk factors include obesity (adipose tissue being less firm in these patients), female sex, 
elderly patients, patients known as having stigmata for character disorders (obsessive 
compulsive tendencies, dementia).  Treatment consists of repositioning the leads, and 
changing them in the event of fracture. Several surgical techniques have been proposed to 
avoid recurrence; implanting the pacemaker generator under the aponevrosis, active lead 
fixation (almost always the case with implantable cardioverter-defibrillators), Parsonet's 
dacron pouches. Patient education, and psychiatric treatment if indicated, should be proposed.  
2.8 Case 8 - Early venous thrombosis after defibrillator with resynchronisation  
(CRT-D) placement 
A 73 year old male has a defibrillator with resynchronisation implanted for ischemic 
cardiomyopathy after an anterior infarction left him with a left ventricular ejection fraction 
of 25%. He had presented an episode of ventricular tachycardia with syncope. Implantation 
of the device was by the subclavian route. There were no immediate post-operative 
complications and good parameters were recorded for all three leads. Three weeks later, the 
patient complains of discomfort in the left arm, followed by oedema of the whole arm, 
forearm and hand (Figure 11); ultrasound and vascular tomodensitometry confirmed 
complete thrombosis of the left subclavian vein, of the axillary vein, leading up until the 
convergence of the jugular vein. Anticoagulation therapy was commenced and evolution 
was slow but favourable in the following weeks. 
 
 
Fig. 11. Oedema of the left arm, forearm and hand caused by massive thrombosis of the 
subclavian vein after defibrillator with Cardiac Resynchronisation Therapy (CRT-D). 
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Comments: Subclavian vein thrombosis is not uncommon. It can occur in about 30% of 
cases, but usually remains asymptomatic due to the rapid development of collateral 
circulation (Oginosawa et al., 2002). Less than 5% of patients are symptomatic, presenting 
mainly with pain or oedema of the arm closest to the implantation site. Risk is higher in 
cases where three leads are implanted (Cardiac Resynchronisation Therapy (CRT), when the 
patient is under hormonal therapy, when personal history of thrombo-embolic event is 
present, with temporary ipsilatérale transvenous lead, during upgrade of a simple 
pacemaker to a pacemaker with resynchronisation, dual coil leads, and when the ejection 
fraction is less than or equal to 40% (Da Costa et al., 2003 ; Rozmus et al., 2005). The risk of 
thrombosis does not differ for pacemakers and implantable cardioverter-defibrillators. 
Preventive measures may be necessary (platelet aggregation inhibiting drugs or 
anticoagulation therapy). 
2.9 Case 9 - Unusual tachycardia after implantation of a double-chamber pacemaker 
A 75 year old male is admitted for repeated fainting caused by major sinus dysfunction as 
shown by a 24 hour Holter monitor which revealed pauses of up to 8 seconds and 
paroxystic atrial fibrillation. Medical history was negative and patient was on no current 
treatment. EKG at rest showed a sinus rhythm with a frequency of 68 bpm and normal 
repolarisation. A physiological pacemaker is implanted in the operating room. After the 
intervention, the patient feels palpitations and an EKG recording shows probable 
pacemaker-mediated tachycardia (Figure 12). Programmation control shows a P-R sensing 
of 15.8 mV and 1.2 mV respectively, and threshold values for stimulation both inferior to 0.5 
volts for 0.4 msec; a connection error is confirmed during threshold verification. 
Programming in AAI mode would result in VVI pacing, and programming in VVI mode 
would result in AAI pacing. Re-intervention allowed the correction of this connection error. 
  
 
Fig. 12. Tachycardia due to an error in the connection of the atrial and ventricular leads. We 
note the same QRS configuration as with VVI pacing from the apex. 
Comments: Atrial and ventricular lead connection errors are rare at implantation, but have 
already been documented (Barold et al, 2010). Programmation verification allows rapid 
detection of the switch (“green wire on the green button and red wire on the red button”). A 
control of the programmation of a stimulator is mandatory before patient discharge. It 
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allows detection and correction of such an error, as well as early detection of a lead 
displacement. Different types of tachycardia are to be excluded: 
• Classical "endless loop" or pacemaker mediated tachycardia is rare with the double 
chamber generators of today.  
• it is usually initiated by an extra-systole with a retrograde p wave which is easily 
detected and sustains the circuit. Pacemaker mediated tachycardia can also be 
provoked by ventricular extra-systoles, by atrial over-detection (myopotentials, 
interferences) or underdetection and failure to capture  
• long post-ventricular atrial refractory period (PVARP), excluding retrograde P 
wave and retrograde conduction, may prevent pacemaker mediated tachycardia  
• Runaway Pacemaker is due to a malfunction of the pacemaker generator resulting in 
life-threatening rapid tachycardia (up to 200 bpm).  
• the generator may malfunction for various causes, including battery failure or 
external damage.  
• the use of a magnet can reduce the rate of the rhythm induced by the defiant 
pacemaker. Generator replacement is necessary. 
• Atrioventricular nodal reentrant tachycardia. In this case, the stimulator does not 
intervene in the circuit.  
• figure 13 shows the initiation of the common type (slow-fast) of atrioventricular 
nodal reentrant tachycardia ; this is a typical example where the arrhythmia is 
triggered by an atrial extrasystole which blocks the rapid pathway of the 
atrioventricular node and allows flow through the slow pathway and thus 
initiation of the supraventricular tachycardia circuit  
• radiofrequency ablation is the treatment of choice. 
• Other reentrant tachycardia includes  
• atrial flutter  
• orthodromic circus movement tachycardia using an accessory pathway in the 
retrograde direction and the AV node in the anterograde direction (concealed or 
not, in the Wolff-Parkinson-White syndrome)  
• atrial tachycardia (paroxysmal and nonparoxysmal) 
 
 
Fig. 13. Baseline rhythm strip showing atrial, ventricular and shock intracardiac electrogram 
leads, and marker atrial and ventricular channels. This is an example of initiation of 
common atrioventricular node reentrant tachycardia; see text.  
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2.10 Case 10 - Recurrent malaise after pacemaker implantation 
A man aged 65 with history positive for high blood pressure, diabetes and renal failure 
actually undergoing haemodialysis receives a pacemaker for complete atrioventricular block 
with syncope. His treatment includes ramipril, aspirin and insulin. No immediate post-
operative complications occur. Just before a haemodialysis session a few days later, the 
patient complains of feeling faint. An EKG shows evident signs of hyperkaliemia (very wide 
QRS complexes with tall peaked T waves and obliteration of the ST segment, as well as a 
long PR interval) and of double chamber stimulation without atrial or ventricular captures 
(Figure 14). Blood work-up confirms severe hyperkaliemia (potassium 7.8 mEq/L). The 
atrioventricular underdetection and the absence of capture are caused by the high level of 
potassium and corrected as soon as kaliemia is normalised by haemodialysis.  
 
 
Fig. 14. Twelve-lead EKG showing signs of hyperkaliemia and defiant AV detection and 
stimulation.   
Comments: Causes of atrioventricular underdetection and failure to capture are shown in 
table I. Hypokaliemia is another cause of life-threatening undersensing (de Meester et al, 
1996). Correction of the cause is essential for adequate pacemaker function. The risk of 
triggering ventricular fibrillation, due to a ventricular stimulation during the vulnerable T 
wave period (R-on-T phenomenon), is present, as is present in asynchronous VOO 
stimulation or the use of a magnet (Oupadia et al., 1998). 
2.11 Case 11 - Important dyspnoea and malaise at follow-up 
A 68 year old patient was admitted for class III dyspnoea according to the New York Heart 
Association (NYHA) score and repeated episodes of malaise since implantation of a single 
chamber pacemaker in another centre. Her personal history is positive for hypertension and 
sick sinus syndrome with atrial fibrillation associated with a slow ventricular rhythm and 
pauses of more than 8 seconds, hence the indication for cardiac pacing. Her treatment is 
comprised of ramipril, amlodipin and an oral anticoagulant, (acenocoumarol). Clinical 
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examination is unremarkable. Blood pressure was 130/80 mmHg. Twelve-lead EKG shows 
regular ventricular stimulation at 70 beats per minute, and a basal sinus rhythm. Dissociated 
P waves are seen (Figure 15). Pacemaker syndrome is suspected, and confirmed. The 
pacemaker was reprogrammed to VVI 30 bpm to avoid deleterious ventricular stimulation 
in this patient. 
 
 
Fig. 15. Twelve-lead EKG showing a dissociated sinus rhythm with right ventricular 
stimulation. 
Comments: This is not a veritable implantation complication but the erroneous choice of a 
single chamber pacemaker whereas a physiological (or double chamber) stimulator would 
have avoided the problem. Pacemaker syndrome is described as a combination of symptoms 
evoking cardiac failure and hypotension in a patient with a cardiac stimulator (Chalvidan et 
al., 2000). It is caused by the loss of atrioventricular synchronism leading to a drop in cardiac 
output, elevated atrial pressure and hypotension. The Mode Selection Trial (MOST) 
investigators defined pacemaker syndrome as occurring if either one of two different criteria 
occurred (Link et al., 2004). The first criterion was new or worsened dyspnea, orthopnea, 
elevated jugular venous pressure, rales, and oedema with ventricular (VA) conduction 
during ventricular pacing. The second criterion was symptoms of dizziness, weakness, 
presyncope, or syncope, and a >20 mmHg reduction of systolic blood pressure when the 
patient had VVIR pacing compared with atrial pacing or sinus rhythm. Its incidence is 7-
20% of stimulators in VVI mode with a sinus rhythm. Pacemaker syndrome can also be seen 
in AAIR mode and in double chamber modes (VDD, DDI, DDD) if the stimulator if 
programmation is sub-optimal or the stimulation mode is incorrectly selected.  Dyspnoea 
should, besides pacemaker syndrome, evoke: 
• chronotrope insufficiency, especially during exertion, requiring programmation in rate-
responsive mode.  
• Wenckeback functioning in DDD mode 
• intermittent dysfunction (sensing and pacing)  
www.intechopen.com
 Early Complications after Pacemaker Implantations 
 
177 
2.12 Case 12 - Acute infection of the pocket and the cardiac device 
A 45 year old female patient suffering from idiopathic congestive cardiomyopathy with a 
left ventricular ejection fraction of 35%, class III dyspnoea on the New York Heart 
Association (NYHA) scale, left bundle branch block morphology, with a QRS duration of 
175 msec, on EKG and under optimal medical treatment for over three months receives a 
pacemaker with left ventricular resynchronisation. Implantation was complicated 
immediately by left ventricular lead displacement. A Starfix Attain OTW 4194 (Medtronic 
Inc., Minneapolis, MN, USA) was necessary for stability (The Attain Starfix’s design 
includes three soft, polyurethane lobes near the lead tip that, when expanded, enable stable 
lead placement in the target location) (de Meester, 2010). After one month, the implantation 
site becomes suppurative (Figure 16). Local wound care and 10 day antibiotherapy did not 
help. Bacteriological studies revealed the presence of pseudomonas aeruginosa. Treatment 
required complete ablation of the material and prolonged antibiotherapy. Re-implantation 
on the counter-lateral side in this case was performed two months after the end of the 
antibiotic course. 
 
 
Fig. 16. Photograph showing suppurative wound with visible pacemaker leads. Ablation of 
all material was necessary.   
Comments: Suture or pocket infection is not a rarity during the first month and incidence is 
estimated to be 1% (del Rio et al., 2003 ; Klug et al., 2007). Principal risk factors are re-
intervention, diabetes, old age, corticoids, operator inexperience, and renal failure. 
Antibiotic prophylaxis prior to pacemaker implantation has a protective effect. In the case of 
very early infection, a per-operatory contamination by cutaneous flora (staphylococcus 
aureus) is the principal source of infection (Kearney et al., 1994 ; Da Costa et al., 1998). 
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Successful treatment of an infected device requires removal of the entire system and 
administration of antimicrobials. Infection after one month usually originates from the lead 
(and not the pocket). Sepsis is uncommon and diagnosis includes positive blood cultures 
(80% of cases) and transesophageal echography showing lead anomalies. Skin erosion at 
pocket site and other local signs of infection are common. Staphylococcus epidermidis or 
other gram negative bacteria are most commonly found.  
3. Conclusions 
Early complications after pacemaker and other cardiac device implantation are not 
uncommon. Hematoma, skin erosion and pocket infection, as well as lead displacement are 
the most common of these complications and should be looked for and recognised during 
routine  follow-up, as well as during work-up of any patient presenting a new symptom  in 
the first couple of weeks after implantation. Operator inexperience and implantation in a 
low-volume centre increases the risk of these complications. Adhesion to good practice and 
recommended guidelines is indispensable. 
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